| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Vertex | 18.6% | 0.2% | -9.2% | -11.6% | 18.8% | | 25.7% | 24.5% |
| Alexion | 11.4% | 0.1% | -3.5% | 0.8% | 0.6% | 1.3% | 13.0% | 13.3% |
| Mylan | 10.7% | 3.4% | 1.8% | -4.2% | 6.8% | 0.6% | 18.9% | 1.0% |
| Takeda | 10.4% | 1.0% | -5.1% | -5.2% | 13.9% | | 33.5% | 21.3% |
| Astra | 8.9% | 0.5% | -6.1% | -6.3% | 16.3% | 10.6% | 16.1% | 15.4% |
| Novo | 7.5% | -0.3% | -1.8% | -1.7% | 1.0% | 1.8% | 7.5% | 9.7% |
| Regeneron | 6.8% | -0.2% | 0.7% | -0.9% | -1.9% | 29.2% | 6.4% | 4.8% |
| Celgene | 6.4% | -0.5% | -2.3% | -3.9% | 1.6% | 0.5% | 9.6% | 10.4% |
| Chugai | 6.0% | 2.9% | -0.9% | -0.5% | 7.0% | 0.6% | 14.5% | 14.6% |
| ONO | 6.0% | 0.1% | -3.9% | -2.3% | 6.0% | 3.3% | 10.9% | 11.1% |
| Glaxo | 5.7% | 0.2% | -1.2% | 1.4% | 0.9% | 0.1% | 5.4% | 4.8% |
| Bayer | 5.4% | 2.3% | -4.4% | -1.5% | 34.7% | -2.8% | 11.3% | 10.3% |
| Merck | 5.1% | 0.4% | -3.6% | -0.3% | 2.9% | -1.0% | 7.6% | 9.8% |
| Merck KG | 4.6% | -0.1% | -1.0% | -1.7% | 9.5% | 2.8% | 7.0% | 7.1% |
| Eisai | 4.3% | 0.6% | 1.2% | -2.9% | 3.7% | 1.5% | 8.0% | 7.9% |
| Daiichi | 4.2% | 1.6% | -1.3% | -0.2% | 11.3% | | 7.4% | 7.4% |
| Bristol | 4.2% | -0.3% | -3.5% | 0.2% | 1.1% | -0.7% | 4.7% | 5.5% |
| Otsuka | 4.1% | 1.0% | -1.1% | -0.5% | 11.3% | 1.1% | 15.7% | 16.7% |
| Roche | 3.6% | 0.2% | -1.1% | -0.8% | 1.3% | -0.2% | 5.1% | 5.0% |
| Sanofi | 3.5% | 0.2% | -2.1% | -1.9% | 4.0% | 0.4% | 5.4% | 5.7% |
| JnJ | 3.2% | 0.3% | -2.2% | -0.6% | 2.2% | 0.9% | 5.1% | 6.2% |
| Amgen | 3.1% | -0.1% | -1.3% | 1.9% | -0.4% | 1.9% | 2.9% | 6.8% |
| AbbVie | 3.0% | -0.8% | -2.4% | -0.9% | -0.3% | 8.4% | 1.8% | 3.7% |
| Astellas | 2.5% | 0.5% | -0.6% | -0.1% | 2.5% | 11.4% | 2.6% | 3.1% |
| Lilly | 2.3% | 1.2% | -2.4% | 1.1% | 3.9% | -1.8% | 6.1% | 9.8% |
| Allergan | 1.1% | -0.1% | 0.8% | 1.6% | -1.2% | -1.6% | 1.5% | 3.0% |
| Gilead | 1.0% | 0.8% | 1.7% | 1.6% | 0.6% | 1.3% | 1.5% | 3.2% |
| UCB | 0.7% | 0.4% | -0.1% | -0.6% | 0.9% | -0.1% | 3.5% | 3.5% |
| Novartis | 0.7% | 0.9% | -1.6% | 1.0% | 4.6% | 0.4% | 5.3% | 5.9% |
| Shionogi | 0.7% | -0.3% | 1.0% | -1.9% | 0.7% | 1.8% | 0.1% | 0.7% |
| M Tanabe | -0.7% | -2.0% | 0.1% | -0.8% | -9.7% | 0.9% | -12.8% | -12.9% |
| Lundbeck | -0.7% | 1.0% | 1.6% | 1.2% | 2.3% | -0.4% | -1.2% | -1.2% |
| Biogen | -1.1% | -0.2% | 1.7% | -1.3% | -0.9% | -2.5% | -1.1% | 2.7% |
| Teva | -1.7% | 0.5% | -0.7% | -0.7% | 0.6% | 2.7% | 1.0% | -0.7% |
| Pfizer | -2.5% | 0.3% | -1.5% | 3.2% | 0.4% | 0.7% | -2.0% | 0.0% |
| Abbvie/Allergan | | | | | | | | |
| Bristol/Celgene | | | | | | | | |
| EU Major | 4.4% | 0.6% | -2.5% | -1.3% | 5.0% | 0.9% | 7.1% | 7.4% |
| Other EU | 3.3% | 0.0% | -0.4% | -1.5% | 5.2% | 2.1% | 5.0% | 4.0% |
| US Major | | | | | | | | |
| US Big Biotech | 4.0% | 0.1% | -0.7% | -0.6% | 0.5% | 6.8% | 5.2% | 7.1% |
| Other US | 2.8% | 1.0% | 0.4% | -1.0% | 1.8% | 1.1% | 6.2% | 2.2% |
| Japanese | 5.6% | 0.8% | -2.1% | -2.2% | 6.6% | 9.3% | 11.4% | 8.5% |